Sugarbaker, 1999, Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients, J Thorac Cardiovasc Surg, 117, 54, 10.1016/S0022-5223(99)70469-1
Zellos, 2002, Multimodality treatment of diffuse malignant pleural mesothelioma, Semin Oncol, 29, 41, 10.1053/sonc.2002.30230
Weder, 2004, Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma, J Clin Oncol, 22, 3451, 10.1200/JCO.2004.10.071
Ruffie, 1989, Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients, J Clin Oncol, 7, 1157, 10.1200/JCO.1989.7.8.1157
Rusch, 2001, A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma, J Thorac Cardiovasc Surg, 122, 788, 10.1067/mtc.2001.116560
Richards, 2006, Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma, J Clin Oncol, 24, 1561, 10.1200/JCO.2005.04.6813
Rusch, 1994, A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma, J Clin Oncol, 12, 1156, 10.1200/JCO.1994.12.6.1156
Refaely, 2001, Resection and perfusion thermochemotherapy: a new approach for the treatment of thymic malignancies with pleural spread, Ann Thorac Surg, 72, 366, 10.1016/S0003-4975(01)02786-2
Sabbatini, 2004, Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II trial, Clin Cancer Res, 10, 2962, 10.1158/1078-0432.CCR-03-0486
Sugarbaker, 2005, Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy, Oncologist, 10, 112, 10.1634/theoncologist.10-2-112
Walker, 2006, Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study, Gynecol Oncol, 100, 27, 10.1016/j.ygyno.2005.11.013
Schiller, 1996, Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival, J Clin Oncol, 14, 1913, 10.1200/JCO.1996.14.6.1913
Kemp, 1996, Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer, J Clin Oncol, 14, 2101, 10.1200/JCO.1996.14.7.2101
Betticher, 1995, Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study, Br J Cancer, 72, 1551, 10.1038/bjc.1995.546
Movsas, 2005, Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01, J Clin Oncol, 23, 2145, 10.1200/JCO.2005.07.167
Hensley, 1999, American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants, J Clin Oncol, 17, 3333, 10.1200/JCO.1999.17.10.3333
Chang, 2004, Innovative therapies: intraoperative intracavitary chemotherapy, Thorac Surg Clin, 14, 549, 10.1016/S1547-4127(04)00109-4
Planting, 1999, Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group, Ann Oncol, 10, 693, 10.1023/A:1008353505916
Take, 1996, Activation of circulating platelets by hyperthermal stress, Eur J Med Res, 1, 562
Pivalizza, 1999, The effects of intentional hyperthermia on the Thrombelastograph and Sonoclot analyser, Int J Hyperthermia, 15, 217, 10.1080/026567399285738
Tamura, 1996, Effects of hyperthermal stress on the fibrinolytic system, Int J Hyperthermia, 12, 31, 10.3109/02656739609023687
Van Haarst, 2002, Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma, Br J Cancer, 86, 342, 10.1038/sj.bjc.6600118
Vogelzang, 2003, Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma, J Clin Oncol, 21, 2636, 10.1200/JCO.2003.11.136
Lardinois, 2006, Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma, J Thorac Cardiovasc Surg, 131, 697, 10.1016/j.jtcvs.2005.08.012